About AMW
Our aim is to provide patients and our partners with innovative medicines. Our biodegradable drug delivery systems help to improve treatment adherence and enable cost-effective therapies.
Based on our technology platform, we build on a growing development pipeline, both in-house and with partners.
We cover the entire value chain, from (co-)development and manufacturing to international commercialization through direct sales or out-licensing. Based on our unique expertise in formulation development, we support both global and local pharmaceutical and biotech partners in the development and manufacture of high-quality products and life-cycle solutions.
We have two approved products, the implants Goserelin and Leuprorelin, which are marketed worldwide through local and global pharma partners.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Pharma
